In Brief: Barre-NMC
This article was originally published in The Tan Sheet
Executive Summary
Barre-NMC: Introduces a private-label version of J&J's Monistat 7, containing 2% miconazole nitrate vaginal cream. The product will be available, the company said, in single- and seven-applicator packages. Barre's ANDA was approved by FDA on March 29. G&W Labs recently announced its own launch of a private-label 2% miconazole nitrate product; its ANDA was approved on Feb. 22 ("The Tan Sheet" April 1, In Brief)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning